{"id":"dimethylaminopropionylphenothiazine","rwe":[],"tags":[{"label":"dimethylaminopropionylphenothiazine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A03AC02","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["dimethylaminopropionylphenothiazine"],"offLabel":[],"synonyms":["dimethylaminopropionylphenothiazine"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"dimethylaminopropionylphenothiazine","explanation":"Imagine your body's cells are like locks, and proteins are like keys that fit into those locks. Dimethylaminopropionylphenothiazine is thought to be a key that fits into a specific lock, allowing it to influence the behavior of cells in some way. However, the exact details of how it works are not yet clear.","oneSentence":"Dimethylaminopropionylphenothiazine is a small molecule that likely works by interacting with a specific protein or receptor in the body.","technicalDetail":"As a member of the dimethylaminopropionylphenothiazine class, this compound likely exerts its effects through a complex interplay of molecular interactions, potentially involving modulation of ion channels, G-protein coupled receptors, or other signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4769","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dimethylaminopropionylphenothiazine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:39:39.630477","biosimilars":[],"competitors":[],"genericName":"dimethylaminopropionylphenothiazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"00435Z54H1","UMLSCUI":"C3652660","ChEMBL_ID":"CHEMBL3707362","DRUGBANK_ID":"DB13672","PUBCHEM_CID":"113918"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A03AC02","allCodes":["A03AC02"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"dimethylaminopropionylphenothiazine","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Dimethylaminopropionylphenothiazine is a small molecule drug of the dimethylaminopropionylphenothiazine class, but limited information is available on its development, commercial status, and clinical use. It is unclear what specific target this compound is designed to modulate or what indications it is approved to treat. As a result, there is no clear understanding of its mechanism of action or key safety considerations. Further research is needed to determine the potential therapeutic applications and risks associated with this compound. Unfortunately, due to the lack of available information, it is difficult to provide a comprehensive summary of this drug.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}